NEW YORK, March 7, 2018 /PRNewswire/ -- Cota Inc., a real-world data and analytics company bridging precision medicine to population health, announced its founder and executive chairman, Andrew Pecora, M.D., and chief scientific officer, Stuart Goldberg, M.D., will speak today, Wednesday, March 7, at the HIMSS Annual Conference & Exhibition (HIMSS18) in Las Vegas, Nevada. The event, taking place at the Venetian Convention Center, brings together 40,000+ health IT professionals, clinicians, executives and vendors from around the world.
During the conference, Dr. Goldberg and Dr. Pecora will deliver a talk titled, "Precise Disease Classification Optimizes Bundled Payments." The session will highlight a case study on engaging with bundled payment arrangements using a precise disease classification system, the Cota Nodal AddressTM (CNA). They will provide an overview of how Cota helped Hackensack Meridian Health (HMH) identify 450 distinct patient types for bundled payments from a 3-year retrospective review of breast cancer patients. Using the CNA, HMH is improving clinical outcomes, reducing care variance and gaining an understanding of their case mix, one of the primary barriers to entering bundled payment models.
The speakers will share results from HMH's ongoing commercial cancer bundle program, guiding attendees on how this type of classification system can help health systems better understand their patient populations and identify and reduce care variances among similar patients treated within a bundled payment model. Dr. Pecora and Dr. Goldberg will also share how to improve one's understanding of treatment patterns at scale with data and outline how to create a data-driven culture to track and better manage bundled payment programs.
"Bundled payments have enormous potential within the healthcare system as it shifts toward value," explained Dr. Pecora. "It is critical for organizations to understand how bundled payments and leveraging a precise disease classification system can reduce care variances and allow organizations to more optimally treat their patient populations. Dr. Goldberg and I are honored to be speaking on this topic among fellow healthcare innovators."
For those interested in attending Dr. Pecora and Dr. Goldberg's presentation, please refer to the following information:
Additional information on the presentation and speakers can be found here. If you are interested in scheduling a meeting or a demo with Cota during the conference, please reach out to Cota via email@example.com.
Cota is a real-world data and analytics company that enables providers, payers and life science companies involved in diagnosing and treating complex diseases to optimize the outcomes of individual patients and lower the overall cost of the patient population served. It is powered by the patented Cota Nodal Address™ (CNA) system, a unique digital classification methodology built by leading physicians and data scientists. The CNA is the first and only system that precisely categorizes patient factors, their diseases and intended therapies, enabling precision medicine at scale.
Cota's technology enriches medical records to create research-grade data and joins it with a suite of analysis, visualization and management tools. This enables providers, payers and life science companies to analyze, report on and research outcomes, costs, treatments and quality at any granularity and stage of the patient journey. The result is a constantly improving system that merges technology and medicine to improve the lives of patients everywhere. For more information, go to www.cotahealthcare.com